The Program Committee is currently working on the development of the program. A preliminary program is presented below.

 Friday 2 December

 Session 1: Presented Data in 2016
 13.15hNews from the AASLD - Approved drugs
 13.45hNews from the AASLD - Future Treatment options
 14.45hGroup picture & Coffee Break
 15.15hIndustry symposium (tbc)
 Session 2: Duration of Therapy
 16.15hThe easy-to-treat patient
 16.45hThe difficult-to-treat patient
 17.15hDebate: (treatment duration related)
 18.00hEnd of Day 1
Workshop dinner

 Saturday 3 December

 Session 3: Special Populations
 8.30hRenal Failure
 9.00hEnd stage Liver Disease
 9.30hTransplant patients
 10.30hCoffee Break
 Session 4: Special Populations
 11.00hRAVs in untreated patients
 11.30hTreatment emerging variants
 12.00hRe-treatment options
 13.00hEnd of Day 2